Literature DB >> 999221

Plasma and red cell lipids in sickle cell disease.

P A Akinyanju, C O Akinyanju.   

Abstract

Lipids, in particular phospholipids, are essential components of membrane systems, and the measurement of phospholipids and cholesterol in plasma and tissues is helpful in diagnosis. Phospholipids represent about 60 to 70% of total red cell (RBC) lipids, while about 25% is free cholesterol. Lipids in RBC are present in a dynamic state of equilibrium, and the RBC have the capacity for rapid exchange of lipids with plasma in several ways. The present study examined the cholesterol and phospholipid levels of plasma and erythrocytes in male patients with sickle cell anemia and in healthy male individuals of comparable age. This was performed with a view to detecting possible differences that might be related to some of the RBC abnormalities which accompany the disease. The results show that plasma lipids are significantly reduced in patients with sickle cell anemia and that RBC cholesterol was higher in sickle cell patients than in normal subjects.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 999221

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  3 in total

1.  Lipoprotein subfraction profile and HDL-associated enzymes in sickle cell disease patients.

Authors:  Oktay H Ozturk; Yesim Can; Zafer Yonden; Sedat Motor; Gonul Oktay; Hasan Kaya; Mutay Aslan
Journal:  Lipids       Date:  2013-10-11       Impact factor: 1.880

2.  Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension.

Authors:  Suzana Zorca; Lita Freeman; Mariana Hildesheim; Darlene Allen; Alan T Remaley; James G Taylor; Gregory J Kato
Journal:  Br J Haematol       Date:  2010-03-08       Impact factor: 6.998

3.  Defects in postabsorptive plasma homeostasis of fatty acids in sickle cell disease.

Authors:  Maciej S Buchowski; Larry L Swift; Sylvie A Akohoue; Sadhna M Shankar; Paul J Flakoll; Naji Abumrad
Journal:  JPEN J Parenter Enteral Nutr       Date:  2007 Jul-Aug       Impact factor: 4.016

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.